TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 127 filers reported holding TERNS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $51,756 | -33.6% | 7,600 | -36.1% | 0.01% | -30.0% |
Q1 2024 | $77,992 | +68.1% | 11,889 | +66.3% | 0.01% | +11.1% |
Q4 2023 | $46,384 | +491.1% | 7,147 | +358.1% | 0.01% | +350.0% |
Q3 2023 | $7,847 | +20.7% | 1,560 | +110.0% | 0.00% | 0.0% |
Q2 2023 | $6,501 | -18.2% | 743 | +10.7% | 0.00% | -33.3% |
Q1 2023 | $7,945 | +103.8% | 671 | +75.2% | 0.00% | +50.0% |
Q4 2022 | $3,899 | +95.0% | 383 | +8.5% | 0.00% | +100.0% |
Q3 2022 | $2,000 | – | 353 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Decheng Capital Management III (Cayman), LLC | 714,285 | $2,121,000 | 0.65% |
Vivo Capital, LLC | 2,675,133 | $7,945,000 | 0.55% |
Samsara BioCapital, LLC | 289,068 | $859,000 | 0.22% |
Orbimed Advisors | 3,791,204 | $11,260,000 | 0.18% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,345,959 | $6,967,000 | 0.16% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,238,800 | $3,679,000 | 0.11% |
Antara Capital LP | 1,074,834 | $3,192,000 | 0.10% |
COWEN AND COMPANY, LLC | 85,000 | $252,000 | 0.02% |
Marquette Asset Management, LLC | 21,802 | $65,000 | 0.02% |
CAAS CAPITAL MANAGEMENT LP | 85,851 | $255,000 | 0.01% |